Director/PDMR Shareholding

James Cropper

15/09/2025 07:00

RNS Number : 2339Z

Cropper(James) PLC

15 September 2025

 

15 September 2025

 

James Cropper plc

(the "Company")

 

Director/PDMR Shareholding

 

The Company has been notified that, on 12 September 2025, David Stirling (Chief Executive Officer) purchased 4,000 ordinary shares of 25p each ("Shares") in the Company. As a result of the transaction, David Stirling holds 13,250 Shares in the Company, representing 0.14% of the Company's issued share capital.

 

Enquiries:

 

James Cropper plc
Matt Ratcliffe, General Counsel and Company Secretary
Tel: +44(0)1539 722002
Shore Capital - Nominated Adviser and Broker
Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden
Tel: +44 (0)207 408 4090
IFC Advisory - Financial PR
Graham Herring, Tim Metcalfe, Zach Cohen
Tel: +44 (0) 203 934 6630
james.cropper@investor-focus.co.uk

 

The following information is included in accordance with Article 19(3) of the Market Abuse Regulation (No. 596/2014):

1.
Details of person discharging managerial responsibilities/person closely associated
a)
Name
David Stirling
2.
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification/amendment
Initial Notification
3.
Details of the issuer
a)
Name
James Cropper plc
b)
Legal Entity Identifier
213800XM78VTDYGBRM93
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.
a)
Description of the
financial instrument
Ordinary Shares of 25 pence each
b)
Identification code of the Financial Instrument
GB0002346053
c)
Nature of the
transaction
Purchase of ordinary shares.
d)
Currency
GBP
e)
Price(s) and volume(s)
Price(s)
Volume(s)
270p
4,000
f)
Aggregated
information
- volume
- Price
- Total
4,000
£2.70
£10,800
g)
Date of the transaction
12 September 2025
h)
Place of the transaction
London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHFLFLEARISLIE